Jfl Life Sciences Limited
Incorporated in 2010, JFL Life Sciences Limited manufactures pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage forms tablets and capsules (general) Solid Oral Dosage forms, and Oral rehydration solutions (ORS).
What Jfl files
- Others44
- Board Meeting17
- Important14
- Updates8
- Dividend/Bonus3
- Results1
JFL LIFE SCIENCES (JFLLIFE) has set March 10, 2026, as the record date for its Rights Issue. Shareholders holding JFLLIFE shares on this date will be eligible to receive 1 new fully paid-up equity share for every 1 share they currently own. This corporate action provides existing investors an opportunity...
JFL Life Sciences will hold an EGM on October 28, 2025, to boost its authorized share capital from Rs 50 Cr to Rs 67.50 Cr. This is a crucial step to facilitate a future Rights Issue, aiming to raise funds for expansion and operational working capital. Only shareholders on record...
JFL Life Sciences has set Friday, August 29, 2025, as the cut-off date for its upcoming 15th Annual General Meeting. Shareholders holding shares by this date will be eligible for the final dividend payout and can participate in e-voting at the AGM. The company's 15th AGM is scheduled for September...